Adiponectin upregulates monocytic activin A but systemic levels are not altered in obesity or type 2 diabetes

Cytokine

Volumn 45, Issue 2, 2009, Pages 86-91

  Weigert, Johanna ^a   Neumeier, Markus ^a   Wanninger, Josef ^a   Schober, Franziska ^a   Sporrer, Daniela ^a   Weber, Markus ^a   Schramm, Andrea ^a   Wurm, Sylvia ^a   Stögbauer, Fabian ^a   Filarsky, Michael ^a   Schäffler, Andreas ^a   Aslanidis, Charalampos ^a   Schölmerich, Jürgen ^a   Buechler, Christa ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Activin A; Adiponectin; Monocyte; Type 2 diabetes

Indexed keywords

ACETYLSALICYLIC ACID; ACTIVIN A; ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; HEPARIN; INSULIN; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PIOGLITAZONE; SULFONYLUREA;

AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; HUMAN; HUMAN CELL; IMMUNOREGULATION; INCUBATION TIME; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SUPERNATANT; UPREGULATION; WAIST HIP RATIO;

ACTIVINS; ADIPONECTIN; AGED; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MAP KINASE SIGNALING SYSTEM; METFORMIN; MIDDLE AGED; MONOCYTES; OBESITY; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 59249100306     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.10.017     Document Type: Article

References (45)

1. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
2. Lara-Castro C., Fu Y., Chung B.H., and Garvey W.T. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol 18 (2007) 263-270
3. Ouchi N., Kihara S., Arita Y., Nishida M., Matsuyama A., Okamoto Y., et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103 (2001) 1057-1063
4. Yokota T., Oritani K., Takahashi I., Ishikawa J., Matsuyama A., Ouchi N., et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96 (2000) 1723-1732
5. Abke S., Neumeier M., Weigert J., Wehrwein G., Eggenhofer E., Schaffler A., et al. Adiponectin-induced secretion of interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1, CCL2) and interleukin-8 (IL-8, CXCL8) is impaired in monocytes from patients with type I diabetes. Cardiovasc Diabetol 5 (2006) 17
6. Neumeier M., Weigert J., Schaffler A., Wehrwein G., Muller-Ladner U., Scholmerich J., et al. Different effects of adiponectin isoforms in human monocytic cells. J Leukoc Biol 79 (2006) 803-808
7. Rovin B.H., and Song H. Chemokine induction by the adipocyte-derived cytokine adiponectin. Clin Immunol 120 (2006) 99-105
8. Saijo S., Nagata K., Nakano Y., Tobe T., and Kobayashi Y. Inhibition by adiponectin of IL-8 production by human macrophages upon coculturing with late apoptotic cells. Biochem Biophys Res Commun 334 (2005) 1180-1183
9. Wolf A.M., Wolf D., Rumpold H., Enrich B., and Tilg H. Adiponectin induces the antiinflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 323 (2004) 630-635
10. Wulster-Radcliffe M.C., Ajuwon K.M., Wang J., Christian J.A., and Spurlock M.E. Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun 316 (2004) 924-929
11. Tsatsanis C., Zacharioudaki V., Androulidaki A., Dermitzaki E., Charalampopoulos I., Minas V., et al. Peripheral factors in the metabolic syndrome: the pivotal role of adiponectin. Ann NY Acad Sci 1083 (2006) 185-195
12. Phillips D.J., Jones K.L., Scheerlinck J.Y., Hedger M.P., and de Kretser D.M. Evidence for activin A and follistatin involvement in the systemic inflammatory response. Mol Cell Endocrinol 180 (2001) 155-162
13. Ohguchi M., Yamato K., Ishihara Y., Koide M., Ueda N., Okahashi N., et al. Activin A regulates the production of mature interleukin-1β and interleukin-1 receptor antagonist in human monocytic cells. J Interferon Cytokine Res 18 (1998) 491-498
14. Nusing R.M., and Barsig J. Induction of prostanoid, nitric oxide, and cytokine formation in rat bone marrow derived macrophages by activin A. Br J Pharmacol 127 (1999) 919-926
15. Kozaki K., Akishita M., Eto M., Yoshizumi M., Toba K., Inoue S., et al. Role of activin A and follistatin in foam cell formation of THP-1 macrophages. Arterioscler Thromb Vasc Biol 17 (1997) 2389-2394
16. Yu J., Shao L.E., Frigon Jr. N.L., Lofgren J., and Schwall R. Induced expression of the new cytokine, activin A, in human monocytes: inhibition by glucocorticoids and retinoic acid. Immunology 88 (1996) 368-374
17. Eramaa M., Hurme M., Stenman U.H., and Ritvos O. Activin A/erythroid differentiation factor is induced during human monocyte activation. J Exp Med 176 (1992) 1449-1452
18. Jones K.L., Brauman J.N., Groome N.P., de Kretser D.M., and Phillips D.J. Activin A release into the circulation is an early event in systemic inflammation and precedes the release of follistatin. Endocrinology 141 (2000) 1905-1908
19. Hirai S., Yamanaka M., Kawachi H., Matsui T., and Yano H. Activin A inhibits differentiation of 3T3-L1 preadipocyte. Mol Cell Endocrinol 232 (2005) 21-26
20. Tontonoz P., and Spiegelman B.M. Fat and beyond: the diverse biology of PPARγ. Annu Rev Biochem 77 (2008) 289-312
21. Swarbrick M.M., and Havel P.J. Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord 6 (2008) 87-102
22. Eldar-Geva T., Spitz I.M., Groome N.P., Margalioth E.J., and Homburg R. Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome. Hum Reprod 16 (2001) 2552-2556
23. Yamauchi T., Nio Y., Maki T., Kobayashi M., Takazawa T., Iwabu M., et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13 (2007) 332-339
24. Tang C.H., Chiu Y.C., Tan T.W., Yang R.S., and Fu W.M. Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B pathway. J Immunol 179 (2007) 5483-5492
25. Scicchitano M.S., McFarland D.C., Tierney L.A., Boyce R.W., Frazier K.S., Schwartz L.W., et al. Role of p38 in regulation of hematopoiesis: effect of p38 inhibition on cytokine production and transcription factor activity in human bone marrow stromal cells. Blood Cells Mol Dis 40 (2008) 370-380
26. Stogbauer F., Neumeier M., Weigert J., Wanninger J., Grandl M., Lehle K., et al. Highly efficient and low-cost method to isolate human blood monocytes with high purity. J Immunol Methods 337 (2008) 78-80
27. Neumeier M., Weigert J., Schaffler A., Weiss T., Kirchner S., Laberer S., et al. Regulation of adiponectin receptor 1 in human hepatocytes by agonists of nuclear receptors. Biochem Biophys Res Commun 334 (2005) 924-929
28. Weigert J., Neumeier M., Wanninger J., Wurm S., Kopp A., Schober F., et al. Reduced response to adiponectin and lower abundance of adiponectin receptor proteins in type 2 diabetic monocytes. FEBS Lett 582 (2008) 1777-1782
29. Schober F., Neumeier M., Weigert J., Wurm S., Wanninger J., Schaffler A., et al. Low molecular weight adiponectin negatively correlates with the waist circumference and monocytic IL-6 release. Biochem Biophys Res Commun 361 (2007) 968-973
30. Tsao T.S., Murrey H.E., Hug C., Lee D.H., and Lodish H.F. Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem 277 (2002) 29359-29362
31. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 26 (2005) 439-451
32. Towler M.C., and Hardie D.G. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 100 (2007) 328-341
33. Wanninger J., Neumeier M., Weigert J., Liebisch G., Weiss T.S., Schaffler A., et al. Metformin reduces cellular lysophosphatidylcholine and thereby may lower apolipoprotein B secretion in primary human hepatocytes. Biochim Biophys Acta 1781 (2008) 321-325
34. Yamakawa T., Ohnaka K., Tanaka S., Utsunomiya H., Kamei J., and Kadonosono K. Cyclooxygenase-2 induction by lysophosphatidylcholine in cultured rat vascular smooth muscle cells: involvement of the p38MAPK pathway. Biomed Res 29 (2008) 1-8
35. Libby P., and Plutzky J. Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-α and peroxisome proliferator-activated receptor-γ agonists. Am J Cardiol 99 (2007) 27B-40B
36. Pascual G., Sullivan A.L., Ogawa S., Gamliel A., Perissi V., Rosenfeld M.G., et al. Antiinflammatory and antidiabetic roles of PPARγ. Novartis Found Symp 286 (2007) 183-196 [discussion 96-203]
37. Huang H., Park P.H., McMullen M.R., and Nagy L.E. Mechanisms for the antiinflammatory effects of adiponectin in macrophages. J Gastroenterol Hepatol 23 Suppl. 1 (2008) S50-S53
38. Wang Y., Xu L.Y., Lam K.S., Lu G., Cooper G.J., and Xu A. Proteomic characterization of human serum proteins associated with the fat-derived hormone adiponectin. Proteomics 6 (2006) 3862-3870
39. Zhu W., Cheng K.K., Vanhoutte P.M., Lam K.S., and Xu A. Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci (Lond) 114 (2008) 361-374
40. Andreozzi F., Laratta E., Cardellini M., Marini M.A., Lauro R., Hribal M.L., et al. Plasma interleukin-6 levels are independently associated with insulin secretion in a cohort of Italian-Caucasian nondiabetic subjects. Diabetes 55 (2006) 2021-2024
41. Muller S., Martin S., Koenig W., Hanifi-Moghaddam P., Rathmann W., Haastert B., et al. Impaired glucose tolerance is associated with increased serum concentrations of interleukin-6 and co-regulated acute-phase proteins but not TNF-α or its receptors. Diabetologia 45 (2002) 805-812
42. Fernandez-Real J.M., Vayreda M., Richart C., Gutierrez C., Broch M., Vendrell J., et al. Circulating interleukin-6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 86 (2001) 1154-1159
43. Wee C.C., Mukamal K.J., Huang A., Davis R.B., McCarthy E.P., and Mittleman M.A. Obesity and C-reactive protein levels among white, black, and hispanic US adults. Obesity (Silver Spring) 16 (2008) 875-880
44. Sutherland J.P., McKinley B., and Eckel R.H. The metabolic syndrome and inflammation. Metab Syndr Relat Disord 2 (2004) 82-104
45. Vejda S., Cranfield M., Peter B., Mellor S.L., Groome N., Schulte-Hermann R., et al. Expression and dimerization of the rat activin subunits βC and βE: evidence for the formation of novel activin dimers. J Mol Endocrinol 28 (2002) 137-148